Avicanna Inc. has filed a preliminary non-offering preliminary prospectus for a proposed initial public offering by way of qualifying the issuance of 540,484 units upon conversion of 540,484 special warrants issued on December 13, 2018 at $8.00 per special warrant.
Avicanna has targeted CSE as the exchange on which it will likely seek a listing.
Toronto based Avicanna aims to establish itself as a leader in the global medical cannabis industry through product discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure.
Avicanna has two wholly-owned subsidiaries, My Cannabis, an Ontario corporation, and Avicanna LATAM a corporation governed by the laws of Colombia. It holds a 70% controlling equity interest in Sativa Nativa S.A.S., a 60% controlling equity interest in Santa Marta Golden Hemp S.A.S, both governed by the laws of Colombia.
Avicanna has raised over $13 million since its inception in November 2016.
photo credit: Avicanna
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.